Judge Denies Investors’ Meritless Reconsideration Bid In Stock-Drop Suit
BROOKLYN, N.Y. — Ruling that lead plaintiffs in a securities class action alleging that a diagnostic testing company and others misrepresented the performance and viability of the company’s COVID-19 test have...To view the full article, register now.
Already a subscriber? Click here to view full article